Glenmark Pharmaceuticals Gets Indian Approval for Favipiravir as a COVID-19 Treatment By Sam | June 22, 2020 Glenmark is also conducting phase 3 trials of favipiravir as a COVID-19 monotherapy. Source: Devices & Diagnostics Letter Posted in Devices & Diagnostics Letter